FRONTIER

1. Antimicrobial peptides and the gut microbiome in inflammatory bowel disease
2. Idiopathic chronic pancreatitis: Beyond antioxidants

OPINION REVIEW

1. COVID-19 as a trigger of irritable bowel syndrome: A review of potential mechanisms

REVIEW

1. Overview of the microbiota in the gut-liver axis in viral B and C hepatitis
2. Hepatocellular carcinoma locoregional therapies: Outcomes and future horizons

MINIREVIEWS

1. Recent advances in artificial intelligence for pancreatic ductal adenocarcinoma
2. Hepatitis B: Who should be treated?-managing patients with chronic hepatitis B during the immunetolerant and immunoactive phases

ORIGINAL ARTICLE

1. Liver injury changes the biological characters of serum small extracellular vesicles and reprograms hepatic macrophages in mice
2. Genome-wide map of N6 -methyladenosine circular RNAs identified in mice model of severe acute pancreatitis
3. Survivin-positive circulating tumor cells as a marker for metastasis of hepatocellular carcinoma

Prospective Study

1. Immunoglobulin G in non-alcoholic steatohepatitis predicts clinical outcome: A prospective multi-centre cohort study

SYSTEMATIC REVIEWS

1. Minimum sample size estimates for trials in inflammatory bowel disease: A systematic review of a support resource